Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001654954-17-001038
Filing Date
2017-02-14
Accepted
2017-02-14 11:56:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT cambermygn201613g.htm SC 13G/A 62149
2 UNDERWRITING AGREEMENT mygn13ga2016ex1filed.htm EX-1 4969
  Complete submission text file 0001654954-17-001038.txt   68609
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 17605335
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LLC (Filed by) CIK: 0001444043 (see all company filings)

EIN.: 421693587 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A